Literature DB >> 21277791

The consistency approach for quality control of vaccines - a strategy to improve quality control and implement 3Rs.

Fabrizio De Mattia1, Jean-Michel Chapsal, Johan Descamps, Marlies Halder, Nicholas Jarrett, Imke Kross, Frederic Mortiaux, Cecile Ponsar, Keith Redhead, Jo McKelvie, Coenraad Hendriksen.   

Abstract

Current batch release testing of established vaccines emphasizes quality control of the final product and is often characterized by extensive use of animals. This report summarises the discussions of a joint ECVAM/EPAA workshop on the applicability of the consistency approach for routine release of human and veterinary vaccines and its potential to reduce animal use. The consistency approach is based upon thorough characterization of the vaccine during development and the principle that the quality of subsequent batches is the consequence of the strict application of a quality system and of a consistent production of batches. The concept of consistency of production is state-of-the-art for new-generation vaccines, where batch release is mainly based on non-animal methods. There is now the opportunity to introduce the approach into established vaccine production, where it has the potential to replace in vivo tests with non-animal tests designed to demonstrate batch quality while maintaining the highest quality standards. The report indicates how this approach may be further developed for application to established human and veterinary vaccines and emphasizes the continuing need for co-ordination and harmonization. It also gives recommendations for work to be undertaken in order to encourage acceptance and implementation of the consistency approach.
Copyright © 2011. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21277791     DOI: 10.1016/j.biologicals.2010.12.001

Source DB:  PubMed          Journal:  Biologicals        ISSN: 1045-1056            Impact factor:   1.856


  12 in total

1.  The importance of animal models in tuberculosis vaccine development.

Authors:  Armando Acosta; Mohd Nor Norazmi; Rogelio Hernandez-Pando; Nadine Alvarez; Reinier Borrero; Juan F Infante; Maria E Sarmiento
Journal:  Malays J Med Sci       Date:  2011-10

2.  Bridging the Gap Between Validation and Implementation of Non-Animal Veterinary Vaccine Potency Testing Methods.

Authors:  Samantha Dozier; Jeffrey Brown; Alistair Currie
Journal:  Animals (Basel)       Date:  2011-11-29       Impact factor: 2.752

3.  Harnessing the power of novel animal-free test methods for the development of COVID-19 drugs and vaccines.

Authors:  Francois Busquet; Thomas Hartung; Giorgia Pallocca; Costanza Rovida; Marcel Leist
Journal:  Arch Toxicol       Date:  2020-05-23       Impact factor: 5.153

4.  Formaldehyde treatment of proteins enhances proteolytic degradation by the endo-lysosomal protease cathepsin S.

Authors:  Thomas J M Michiels; Hugo D Meiring; Wim Jiskoot; Gideon F A Kersten; Bernard Metz
Journal:  Sci Rep       Date:  2020-07-14       Impact factor: 4.379

5.  Raman spectroscopy-based identification of toxoid vaccine products.

Authors:  Anja Silge; Thomas Bocklitz; Bjoern Becker; Walter Matheis; Juergen Popp; Isabelle Bekeredjian-Ding
Journal:  NPJ Vaccines       Date:  2018-10-04       Impact factor: 7.344

6.  Identity, Structure and Compositional Analysis of Aluminum Phosphate Adsorbed Pediatric Quadrivalent and Pentavalent Vaccines.

Authors:  Kristen Kalbfleisch; Sasmit Deshmukh; Carmen Mei; Moriam Ore; Wayne Williams; Ibrahim Durowoju; Jessica Duprez; Sylvie Morin; Bruce Carpick; Marina Kirkitadze
Journal:  Comput Struct Biotechnol J       Date:  2018-11-29       Impact factor: 7.271

7.  Animal testing for vaccines. Implementing replacement, reduction and refinement: challenges and priorities.

Authors:  Arnoud Akkermans; Jean-Michel Chapsal; Eliana M Coccia; Hilde Depraetere; Jean-François Dierick; Parichat Duangkhae; Sunil Goel; Marlies Halder; Coenraad Hendriksen; Robin Levis; Koraphong Pinyosukhee; Dieter Pullirsch; Gautam Sanyal; Li Shi; Robert Sitrin; Dean Smith; Paul Stickings; Eriko Terao; Sylvie Uhlrich; Laura Viviani; Jim Webster
Journal:  Biologicals       Date:  2020-10-08       Impact factor: 1.856

8.  Degradomics-Based Analysis of Tetanus Toxoids as a Quality Control Assay.

Authors:  Thomas J M Michiels; Wichard Tilstra; Martin R J Hamzink; Justin W de Ridder; Maarten Danial; Hugo D Meiring; Gideon F A Kersten; Wim Jiskoot; Bernard Metz
Journal:  Vaccines (Basel)       Date:  2020-12-01

Review 9.  Recent advances, approaches and challenges in targeting pathways for potential COVID-19 vaccines development.

Authors:  Daniela Calina; Chandan Sarkar; Andreea Letitia Arsene; Bahare Salehi; Anca Oana Docea; Milon Mondal; Muhammad Torequl Islam; Alireza Zali; Javad Sharifi-Rad
Journal:  Immunol Res       Date:  2020-10-01       Impact factor: 2.829

10.  Regulation of Clostridium tetani Neurotoxin Expression by Culture Conditions.

Authors:  Jeroen L A Pennings; Eric Abachin; Raphaël Esson; Hennie Hodemaekers; Antoine Francotte; Jean-Baptiste Claude; Céline Vanhee; Sylvie Uhlrich; Rob J Vandebriel
Journal:  Toxins (Basel)       Date:  2022-01-02       Impact factor: 4.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.